Designed for both point-of-care and over-the-counter use, the innovation is capable of identifying and distinguishing between COVID-19, Influenza A, and Influenza B within just 20 minutes. Aside from being efficient in respiratory virus detection, Aptitude Medical Systems’ cutting-edge diagnostic tool is also versatile as it can be used in different settings, including at home and in CLIA-waived healthcare environments.

The Metrix® COVID/Flu multiplex molecular test’s ability to deliver lab-quality results quickly and affordably addresses longstanding challenges in molecular diagnostics. By bridging the gap between advanced molecular diagnostics and everyday usability, the Metrix® COVID/Flu test represents a transformative step forward in managing respiratory illnesses.

Image Credit: Aptitude Medical Systems